Monitoring and improving hypertension management in Xinjiang
Prognostic Model of Hypertension
Xinjiang Medical University · NCT06160921
This study is trying to improve how people with high blood pressure are treated in Xinjiang by tracking their health and treatment over ten years to find better ways to manage their condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50000 (estimated) |
| Sex | All |
| Sponsor | Xinjiang Medical University (other) |
| Locations | 1 site (Ürümqi, Xinjiang) |
| Trial ID | NCT06160921 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a comprehensive registration and monitoring system for patients with hypertension in Xinjiang from 2020 to 2030. It will collect real-world data on patient characteristics, treatment patterns, hospitalization outcomes, and complications associated with hypertension. The study seeks to develop effective treatment strategies and prevention guidelines to optimize patient management and reduce morbidity and mortality related to hypertension. By creating a platform for clinical research and translational medicine, the study aims to enhance the quality of care for hypertension patients in the region.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with primary hypertension who are admitted to the First Affiliated Hospital of Xinjiang Medical University.
Not a fit: Patients with secondary hypertension, liver and kidney dysfunction, mental disorders, or those unwilling to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and outcomes for patients with hypertension.
How similar studies have performed: While similar observational studies have been conducted, this specific approach in Xinjiang is novel and aims to address local healthcare needs.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * A patient diagnosed with primary hypertension who was admitted to the First Affiliated Hospital of Xinjiang Medical University Exclusion Criteria: * Patients with secondary hypertension, patients with liver and kidney dysfunction, * patients with mental disorders, and patients who are unwilling to participate in this trial
Where this trial is running
Ürümqi, Xinjiang
- The First Affiliated Hospital of Xinjiang Medicial University — Ürümqi, Xinjiang, China (RECRUITING)
Study contacts
- Study coordinator: Xiang Xie, Phd
- Email: xiangxie999@sina.com
- Phone: 15099169036
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hypertension